Yichen Cao

6.5k total citations · 1 hit paper
16 papers, 1.7k citations indexed

About

Yichen Cao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Yichen Cao has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yichen Cao's work include Cancer Mechanisms and Therapy (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). Yichen Cao is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). Yichen Cao collaborates with scholars based in United States, China and France. Yichen Cao's co-authors include Dean Wilkie, Christopher Carter, Scott M. Wilhelm, Xiaomei Zhang, Charles Chen, Mark Lynch, Li Liu, Ralph Buttyan, Alexandre de la Taille and Martin Burchardt and has published in prestigious journals such as Blood, Cancer Research and The Journal of Urology.

In The Last Decade

Yichen Cao

15 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5

2006 1.3k citations Li Liu, Yichen Cao et al. Cancer Research profile →

Peers

Countries citing papers authored by Yichen Cao

Since Specialization

Citations

This map shows the geographic impact of Yichen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichen Cao more than expected).

Fields of papers citing papers by Yichen Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichen Cao. The network helps show where Yichen Cao may publish in the future.

Co-authorship network of co-authors of Yichen Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yichen Cao. A scholar is included among the top collaborators of Yichen Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichen Cao. Yichen Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Mechanical force determines chimeric antigen receptor microclustering and signaling 2024 ·Molecular Therapy ·Yue Qiu, (unknown), Yucai Wang, Yichen Cao, Jing Wang, Zhengpeng Wan, Xiangjun Chen, Wanli Liu, Li L, Chenguang Xu	2
2	Dandelion-like titanium nitride supported platinum as an efficient oxygen reduction catalyst in acidic media 2022 ·International Journal of Hydrogen Energy ·(unknown), Yichen Cao, Zhijie Zhang, Yanxiong Fang, Quanbing Liu, Dai Dang, Yuying Zheng	18
3	Construing travelers’ choice on peer-to-peer accommodation-sharing platform: an investigation into cultural identity and accommodation type 2022 ·Tingting Hou, Shixuan Fu, Yichen Cao, Xiaojiang Zheng, (unknown)	0
4	Towards Understanding Android System Vulnerabilities 2019 ·Institutional Knowledge (InK) - Institutional Knowledge at Singapore Management University (Singapore Management University) ·Daoyuan Wu, Debin Gao, (unknown), Yichen Cao, Jintao Jiang, Robert H. Deng	6
5	Preparation and Biomechanical Properties of an Acellular Porcine Corneal Stroma 2017 ·Cornea ·(unknown), Hongmei Wang, (unknown), Yichen Cao, (unknown)	31
6	Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models 2017 ·eLife ·Hui Qin Wang, Ensar Halilovic, Xiaoyan Li, Jinsheng Liang, Yichen Cao, Daniel P. Rakiec, David A. Ruddy, Sébastien Jeay, Jens Wuerthner, (unknown), Shailaja Kasibhatla, Nanxin Li, Juliet Williams, William R. Sellers, Alan Huang, Fang Li	34
7	Abstract 3516: AZD1208 PIM kinase inhibitor - Preliminary evidence of target pathway inhibition in Phase I clinical trials of AML. 2013 ·Cancer Research ·Kristen McEachern, Yichen Cao, Rachel DuPont, Lourdes Pablo, Patricia McCoon, Jörge E. Cortes, Daniel J. DeAngelo, Mark D. Minden, Becker Hewes, Jeffrey L. Brown, Carl Barrett	1
8	Abstract 2796: Efficacy and biomarker modulation by AZD1208, a novel, potent and selective pan-Pim kinase inhibitor, in models of acute myeloid leukemia 2012 ·Cancer Research ·Erika Krasnickas Keeton, Kristen McEachern, Marat Alimzhanov, Suping Wang, Yichen Cao, (unknown), Sangeetha Palakurthi, Michael Grondine, Yuching Chen, Keith Dillman, Dharmaraj Chinnappan, Minhui Shen, Les A. Dakin, Xiaolan Zheng, Michelle L. Lamb, Allan Wu, Huawei Chen, Paul D. Lyne, Dennis Huszar	3
9	AZD1208, a Novel, Potent and Selective Pan PIM Kinase Inhibitor, Demonstrates Efficacy in Models of Acute Myeloid Leukemia 2011 ·Blood ·Erika Krasnickas Keeton, Sangeetha Palakurthi, Marat Alimzhanov, Michael Grondine, Yuching Chen, Jeffrey S. Brown, Kristen McEachern, Yichen Cao, Dharmaraj Chinnappan, Minhui Shen, Les A. Dakin, Xiao-Feng Zheng, Michelle L. Lamb, Allan Wu, Huawei Chen, Paul D. Lyne, Dennis Huszar	8
10	Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5 breakdown → 2006 ·Cancer Research ·Li Liu, Yichen Cao, Charles Chen, Xiaomei Zhang, (unknown), Dean Wilkie, Scott M. Wilhelm, Mark Lynch, Christopher Carter	1273
11	Blood-based RT-PCR assays of MN/CA9 or PSMA: clinical application in renal cancer patients 2000 ·Urology ·Alexandre de la Taille, Aaron E. Katz, Yichen Cao, James M. McKiernan, Ralph Buttyan, Martin Burchardt, Tatjana Burchardt, Omar Hayek, Carl A. Olsson, Dominique Chopin, Ihor S. Sawczuk	17
12	Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: Long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy 1999 ·International Journal of Cancer ·Alexandre de la Taille, Carl A. Olsson, Ralph Buttyan, Mitchell C. Benson, Emilia Bagiella, Yichen Cao, Martin Burchardt, Dominique Chopin, Aaron E. Katz	44
13	TRANSDIFFERENTIATION OF PROSTATE CANCER CELLS TO A NEUROENDOCRINE CELL PHENOTYPE IN VITRO AND IN VIVO 1999 ·The Journal of Urology ·Tatjana Burchardt, Martin Burchardt, (unknown), Yichen Cao, Alexandre de la Taille, (unknown), Omar Hayek, Thambi Dorai, Ralph Buttyan	13
14	TRANSDIFFERENTIATION OF PROSTATE CANCER CELLS TO A NEUROENDOCRINE CELL PHENOTYPE IN VITRO AND IN VIVO 1999 ·The Journal of Urology ·Tatjana Burchardt, Martin Burchardt, Min‐Wei Chen, Yichen Cao, Alexandre de la Taille, (unknown), Omar Hayek, Thambi Dorai, Ralph Buttyan	144
15	Preoperative Reverse Transcriptase Polymerase Chain Reaction for Prostate Specific Antigen Predicts Treatment Failure Following Radical Prostatectomy 1996 ·The Journal of Urology ·Carl A. Olsson, Glen M. de Vries, Anthony J. Raffo, Mitchell C. Benson, Kathleen O’Toole, Yichen Cao, Ralph Buttyan, Aaron E. Katz	2
16	Preoperative Reverse Transcriptase Polymerase Chain Reaction for Prostate Specific Antigen Predicts Treatment Failure Following Radical Prostatectomy 1996 ·The Journal of Urology ·Carl A. Olsson, Glen M. de Vries, Anthony J. Raffo, Mitchell C. Benson, Kathleen O’Toole, Yichen Cao, Ralph Buttyan, Aaron E. Katz	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact